Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Funding for 2-year projects focused on characterizing, identifying, treating or overcoming/preventing resistance to therapies in tumors harboring alterations in oncogenic drivers in NSCLC cells, tissues, mouse models, or patients.
Característiques principals
We encourage applications on a wide variety of topics related to EGFR, MET or KRAS-driven lung cancer, including, but not limited to the following:
  • Biology and mechanisms of tumor progression
  • Mechanisms of resistance to targeted therapies
  • Novel treatment approaches, combinations, and new therapies
  • Studies on the immune landscape, tumor microenvironment, and immunotherapies

    Additional specific topics of interest related to the individual oncogenic drivers are listed in the RFP document.
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: cbarnwell@imim.es Ext.: 1670
    Marta López: mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    https://www.lungcancerresearchfoundation.org/research/funding-opportunities-2022/
    Grant application system:
    https://proposalcentral.com
    Requisits
    Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment.
    Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status. Senior investigators with more than ten years’ experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics. Ineligible investigators with these or other special circumstances may request review by contacting the LCRF grants office.
    Dotació
    $150,000 for a period of two years (disbursed at $75,000 per year). The LCRF grant must be the primary source of support for the project.
    Durada
    2 years

    Arxius

    Arxiu
    LCRF-GRANTRFP-ONCOGENE-FY22-FINAL.pdf